The Treatment of Pregnant Women with Opioid Use Disorders
$10.50 | CE Hours:3.50 | Intermediate
Not approved for CNAs
*ICB Credit for Counselor I or II, Preventionist I or II, CARS I or II, MISA I or II, PCGC II, CCJP II, CRSS II, MAATP I or II, NCRS II, CFPP II, GCE
CE Course Description
The pattern of initiating heroin use has changed over the past decade and when pregnant women use opioids, their infants may be affected. This CE course provides background information on the treatment of pregnant women with opioid use disorders, summarizes key aspects of guidelines that have been adopted by professional organizations, presents a comprehensive framework to organize these efforts in communities, and provides a collaborative practice guide for community planning to improve outcomes for these families.
Article Author: Sharon Amatetti, M.P.H., served as the author and government project officer from SAMHSA; Elaine Stedt, M.S.W., served as the project officer for the Children’s Bureau of ACF; Nancy K. Young, Ph.D., served as the author and project director from the NCSACW; and Kari Earle, M.Ed., and Erin Hall, M.S.O.T., served as the authors from the NCSACW.
Exam writer: Patricia Hocking-Walker, M.S. (Psychology)
CE Course Objectives
1. Discuss the expert recommendations for countering misinformation about pregnant women and prescription opioid use.
2. Investigate what is a recommended best practice for the care of pregnant women with opioid use disorders.
3. Examine the standard of care for the infant with neonatal abstinence syndrome.
4. Elucidate what medication-assisted treatment includes.
5. Identify the factors that can affect an infant’s withdrawal symptoms.
6. Describe what must be taken into account when making decisions about whether to intervene and how to do so in the most supportive manner.